-
Mashup Score: 36Search for FDA Guidance Documents - 2 day(s) ago
Search for official FDA guidance documents and other regulatory guidance for all topics
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9OCE Pediatric Oncology Program - 2 day(s) ago
Promoting the development of safe and effective new drugs and biologics to treat cancer in children
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Trading Places: Regulator as Patient, Patient as Regulator - 2 day(s) ago
This session at the AACR Annual Meeting 2024 explored how being a patient or caregiver has impacted how drugs and clinical trials are reviewed within the U.S. FDA.…
Source: vimeo.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4OCE Oncology News - 3 day(s) ago
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 66Project Asha - 4 day(s) ago
Collaboration to increase cancer clinical trial access in India
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Professional Education and Resources - 4 day(s) ago
Oncology Center of Excellence professional education projects and resources – 2023 OCE Annual Report
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 34
On April 23, 2024, the Food and Drug Administration granted accelerated approval to tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.) for patients 6 months
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16Conversations on Cancer: Strength in Numbers, Increasing Cancer Awareness and Decreasing Disparities - 4 day(s) ago
April is National Minority Health Month created to reduce health disparities and raise awareness about improving the health of racial and ethnic minority com…
Source: www.youtube.comCategories: General Medicine News, Onc News and JournalsTweet-
We extend our gratitude to the panelists and participants of yesterday's #ConversationsonCancer. The discussion provided valuable insights into collaborative efforts to enhance cancer awareness and minimize disparities. #OCEProjectCommunity Watch replay: https://t.co/gsPnxdQrVj https://t.co/spObe4nqxV
-
-
Mashup Score: 18
On April 23, 2024, the Food and Drug Administration approved lutetium Lu 177 dotatate (Lutathera, Advanced Accelerator Applications USA, Inc., a Novartis compan
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 32
On April 23, 2024, the Food and Drug Administration granted accelerated approval to tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.) for patients 6 months
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
On April 26, 2024, the FDA issued 3 draft guidance documents on eligibility criteria in cancer clinical trials to address: 📝 performance status ⌛ washout periods 💊 📊 concomitant medications and laboratory values https://t.co/97lmKVF20z search "eligibility" https://t.co/81ThpvmMyi